Earnings Call · Q1 FY2024·2024-05-14

Q1 24EPS +100.00%*·Rev n/aQ4 23EPS -100.00%*·Rev n/aQ3 23EPS +46.15%·Rev n/aQ2 23EPS -31.25%·Rev n/a⚠ consensus missing

FENNEC PHARMACEUTICALS INC. FENC

Robert Andrade — Chief Financial Officer (CFO)

Rostislav Raykov — Chief Executive Officer (CEO)

Adrian Haigh — Commercial/Marketing Executive

−1.0%1d on move date−0.8% vs SPY3d+1.1%5d−0.1%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more FENC calls or request research access.

More FENC calls Browse calls Request research access